Skip to main content

Grey Ledge Advisors, LLC

Position in NVO — Novo Nordisk A S

CIK 1660694 GUILFORD, CT

Position in NVO

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$1,048,831
+$144,818 QoQ
Shares Held
21,878
-11.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#518
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Grey Ledge Advisors, LLC holds $20,654,452 across 8 Drug Manufacturers - General names. NVO ranks #6 (5.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NVO
Novo Nordisk A S
This page
21,878 $1,048,831

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,048,831 21,878
2026-03-31 $904,013 24,599
2025-12-31 $1,269,150 24,944
2025-09-30 $1,392,355 25,092
2025-06-30 $1,588,081 23,009
2025-03-31 $1,749,471 25,194
2024-12-31 $2,098,371 24,394
2024-09-30 $1,479,325 12,424
2024-06-30 $1,945,260 13,628
2024-03-31 $1,744,827 13,589
2023-12-31 $1,471,369 14,223
2023-09-30 $1,275,251 14,023
2023-06-30 $1,241,721 7,673
2023-03-31 $1,174,930 7,383
2022-12-31 $1,154,585 8,531
2022-09-30 $862,397 8,656
2022-06-30 $962,755 8,640
2022-03-31 $1,271,189 11,447
2021-12-31 $1,402,464 12,522
2021-09-30 $324,321 3,378
2021-06-30 $1,105,596 13,198
2021-03-31 $885,292 13,131
2020-12-31 $235,953 3,378
2020-09-30 $234,534 3,378
2020-06-30 $221,191 3,378
2020-03-31 $203,355 3,378